Treatment efficacy and glucose variability control of exenatide versus biphasic insulin aspart 30 in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicenter, randomized, open-label, parallel study

被引：0
|
作者：
Liu, Xiangyang [1 ]
Ji, Qiuhe [1 ]
Yang, Wenjuan [2 ]
Liu, Jianrong [3 ]
Gao, Xiling [4 ]
He, Qingzhen [5 ]
Ma, Kaiyan [6 ]
Tian, Zhufang [7 ]
Xie, Xuan [8 ]
机构：
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol, Xian, Shaanxi, Peoples R China
[2] Shaanxi Aerosp Hosp, Dept Endocrinol, Xian, Shannxi Provinc, Peoples R China
[3] Xian Chang An Hosp, Dept Endocrinol, Xian, Shannxi Provinc, Peoples R China
[4] Yanan Peoples Hosp, Dept Endocrinol, Yanan, Shannxi Provinc, Peoples R China
[5] Xian Gaoxin Hosp, Dept Endocrinol, Xian, Shannxi Provinc, Peoples R China
[6] Shangluo Cent Hosp, Dept Endocrinol, Shangluo, Shannxi Provinc, Peoples R China
[7] Xian Cent Hosp, Dept Endocrinol, Xian, Shannxi Provinc, Peoples R China
[8] Xi An Jiao Tong Univ, Dept Endocrinol, Affiliated Hosp 2, Xian, Shannxi Provinc, Peoples R China
来源：
DIABETES-METABOLISM RESEARCH AND REVIEWS | 2018年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1053987
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of insulin degludec biosimilar B01411 versus originator insulin degludec in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs: a multicenter, randomized, open-label, phase 3 study
    Ji, Linong
    Gao, Leili
    Cheng, Zhifeng
    Ma, Guoqing
    Li, Shu
    Wang, Haifang
    Liu, Jie
    Lu, Yibing
    Liu, Meiying
    Geng, Jianlin
    Gao, Yunming
    Ling, Hongwei
    Sun, Wenli
    Song, Chengwei
    Sun, Jingfang
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (10) : 1697 - 1703
  • [22] Comparison of Acarbose and Voglibose in Diabetes Patients Who Are Inadequately Controlled with Basal Insulin Treatment: Randomized, Parallel, Open-Label, Active-Controlled Study
    Lee, Mi Young
    Choi, Dong Seop
    Lee, Moon Kyu
    Lee, Hyoung Woo
    Park, Tae Sun
    Kim, Doo Man
    Chung, Choon Hee
    Kim, Duk Kyu
    Kim, In Joo
    Jang, Hak Chul
    Park, Yong Soo
    Kwon, Hyuk Sang
    Lee, Seung Hun
    Shin, Hee Kang
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (01) : 90 - 97
  • [23] Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study
    Balaji, Vijayam
    Balaji, Madhuri S.
    Alexander, Cynthia
    Srinivasan, Ashalata
    Suganthi, Sheela R.
    Thiyagarajah, Arthi
    Seshiah, Veerasamy
    GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (07) : 529 - 532
  • [24] The effect of glargine versus glimepiride on pancreatic β-cell function in patients with type 2 diabetes uncontrolled on metformin monotherapy: open-label, randomized, controlled study
    Jun Sung Moon
    Kyoung Soo Ha
    Ji Sung Yoon
    Hyoung Woo Lee
    Hyun Chul Lee
    Kyu Chang Won
    Acta Diabetologica, 2014, 51 : 277 - 285
  • [25] The effect of glargine versus glimepiride on pancreatic β-cell function in patients with type 2 diabetes uncontrolled on metformin monotherapy: open-label, randomized, controlled study
    Moon, Jun Sung
    Ha, Kyoung Soo
    Yoon, Ji Sung
    Lee, Hyoung Woo
    Lee, Hyun Chul
    Won, Kyu Chang
    ACTA DIABETOLOGICA, 2014, 51 (02) : 277 - 285
  • [26] The Efficacy and Safety of Insulin Aspart 30 plus Metformin vs. Insulin Aspart 30 Alone in Treatment for Subjects with Type 2 Diabetes: A Randomized Controlled Trial
    Guo, Lixin, Sr.
    Chen, Li
    Chang, Bao Cheng
    Yang, Li Yong
    Liu, Yu
    Feng, Bo
    DIABETES, 2017, 66 : A255 - A255
  • [27] Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea
    Kim, Hye-soon
    Kim, Doo-man
    Cha, Bong-soo
    Park, Tae Sun
    Kim, Kyoung-ah
    Kim, Dong-lim
    Chung, Choon Hee
    Park, Jeong-hyun
    Jang, Hak Chul
    Choi, Dong-seop
    JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (06) : 701 - 708
  • [28] Efficacy and Safety of Avandamet or Uptitrated Metformin Treatment in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Alone: A Multicenter, Randomized, Controlled Trial
    Cai Xiao-Ling
    Chen Ying-Li
    Zhao Jia-Jun
    Shan Zhong-Yan
    Qiu Ming-Cai
    Li Cheng-Jiang
    Gu Wei
    Tian Hao-Ming
    Yang Hua-Zhang
    Xue Yao-Ming
    Yang Jin-Kui
    Hong Tian-Pei
    Ji Li-Nong
    中华医学杂志英文版, 2015, 128 (10) : 1279 - 1287
  • [29] Efficacy and Safety of Avandamet or Uptitrated Metformin Treatment in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Alone: A Multicenter, Randomized, Controlled Trial
    Cai, Xiao-Ling
    Chen, Ying-Li
    Zhao, Jia-Jun
    Shan, Zhong-Yan
    Qiu, Ming-Cai
    Li, Cheng-Jiang
    Gu, Wei
    Tian, Hao-Ming
    Yang, Hua-Zhang
    Xue, Yao-Ming
    Yang, Jin-Kui
    Hong, Tian-Pei
    Ji, Li-Nong
    CHINESE MEDICAL JOURNAL, 2015, 128 (10) : 1279 - 1287
  • [30] The efficacy and safety of beinaglutide alone or in combination with insulin glargine in Chinese patients with type 2 diabetes mellitus who are inadequately controlled with oral antihyperglycemic therapy: A multicenter, open-label, randomized trial
    Liu, Xiangyang
    Yang, Wenjuan
    Liu, Jianrong
    Huang, Xinxi
    Fang, Yujie
    Ming, Jie
    Lai, Jingbo
    Fu, Jianfang
    Ji, Qiuhe
    Wang, Li
    JOURNAL OF DIABETES, 2024, 16 (02)
12345